Europe · Wires & real time · MarketScreener

Jefferies raises target price for Genmab, boosts view on oncology portfolio

Published by MarketScreener · France 13 h ago

Jefferies reiterates its Buy rating on Danish pharmaceutical company Genmab and raises its target price to DKK 3,200 from DKK 2,900. The research firm sees stronger potential for…

Read the full article on MarketScreener Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketscreener.com)

Also worth reading

TASS

Kremlin aide describes coming week in Putin’s schedule as ‘extremely tight’

Anadolu Agency

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

Reuters Technology

Jefferies raises target price for Genmab, boosts view on oncology portfolio

Share

Also worth reading

Kremlin aide describes coming week in Putin’s schedule as ‘extremely tight’

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

AI gloom revives the specter of stagflation

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long